Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119822
Chunk: 162

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 162
---
 Common Stock.

Our Warrants are exercisable for our Common Stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.

As of March 31, 2025, we have 6,958,309 SPAC Warrants outstanding, which are currently exercisable for an aggregate of up to 198,810
shares of our Common Stock in accordance with the terms of the Warrant Agreement, dated as of January 6, 2021, between Continental, as warrant agent, and Vickers, governing those securities. The exercise price of these SPAC Warrants is $402.50
per whole share.

As of March 31, 2025, (i) outstanding Penny Warrants to purchase an aggregate of 6,500,000 shares of our Common
Stock are exercisable under the terms thereof, the exercise price of which is $0.01 per share, (ii) outstanding February 2024 BDO Firm Warrants (as defined below) to purchase an aggregate of 108,686 shares of our Common Stock are exercisable
under the terms thereof, the exercise price of which is $59.50 per share; (iii) outstanding February 2024 BDO Representative Warrants (as defined below) to purchase an aggregate of 13,446 shares of our Common Stock are exercisable under the
terms thereof, the exercise price of which is $74.38 per share; (iv) outstanding Deposit Warrant (as defined below) to purchase an aggregate of 3,250,000 shares of our Common Stock are exercisable under the terms thereof, the exercise price of
which is $1.20 per share, (v) outstanding April 2024 RDO Common Warrants (as defined below) to purchase an aggregate of

100

428,572 shares of our Common Stock are exercisable under the terms thereof, the exercise price of which is $38.50 per share and (vi) outstanding April 2024 RDO Placement Agent Warrants (as
defined below) to purchase an aggregate of 34,286 shares of our Common Stock are exercisable under the terms thereof, the exercise price of which is $43.75 per share.

On October 8, 2024, we issued the October 2024 Noteholder Warrants (as defined below) to purchase an aggregate of 214,284 shares of
Common Stock, which are exercisable as of the date of